Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (116)
The Brief Psychiatric Rating Scale
1962 • 10,683 citations
Clozapine for the Treatment-Resistant Schizophrenic
1988 • 4,030 citations
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
1987 • 3,683 citations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 • 3,182 citations
Recent advances in the phencyclidine model of schizophrenia
1991 • 2,886 citations
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
1976 • 2,224 citations
Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
1963 • 2,148 citations
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
1986 • 2,026 citations
Rapid Automated Algorithm for Aligning and Reslicing PET Images
1992 • 1,958 citations
Molecular pathology of schizophrenia: more than one disease process?
1980 • 1,877 citations
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
1991 • 1,819 citations
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 • 1,743 citations
Glutamate Receptor Dysfunction and Schizophrenia
1995 • 1,682 citations
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999 • 1,300 citations
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
1996 • 1,275 citations
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
1997 • 1,147 citations
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
1990 • 1,102 citations
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
1998 • 1,002 citations
Imaging Synaptic Neurotransmission within VivoBinding Competition Techniques: A Critical Review
2000 • 938 citations
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
1995 • 891 citations
Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons
1975 • 874 citations
Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
1992 • 832 citations
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
1998 • 786 citations
Increased dopamine transmission in schizophrenia: relationship to illness phases
1999 • 713 citations
Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
1993 • 713 citations
Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia
1997 • 665 citations
Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
1999 • 593 citations
Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats
1989 • 562 citations
Provocative tests with psychostimulant drugs in schizophrenia
1987 • 535 citations
Phencyclidine-induced psychosis
1978 • 482 citations
Pharmacology of mesocortical dopamine neurons.
1983 • 478 citations
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
1970 • 475 citations
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
1999 • 452 citations
NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine
1996 • 450 citations
Prefrontal function in schizophrenia: confounds and controversies
1996 • 420 citations
Advances in pharmacology
1962 • 412 citations
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
1997 • 393 citations
Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo
1993 • 386 citations
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia
1985 • 373 citations
The Prefrontal Cortex Regulates the Basal Release of Dopamine in the Limbic Striatum: An Effect Mediated by Ventral Tegmental Area
1996 • 365 citations
Tonic Activation of NMDA Receptors Causes Spontaneous Burst Discharge of Rat Midbrain Dopamine Neurons In Vivo
1993 • 350 citations
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
1997 • 349 citations
The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies
2000 • 332 citations
SPECT imaging of striatal dopamine release after amphetamine challenge.
1995 • 330 citations
Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area
1992 • 315 citations
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress
1990 • 308 citations
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 • 305 citations
The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia
1991 • 287 citations
Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices
1988 • 281 citations
Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses
1990 • 279 citations
Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro
1987 • 239 citations
Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area
1985 • 231 citations
Iontophoretically administered drugs acting at the N‐methyl‐D‐aspartate receptor modulate burst firing in A9 dopamine neurons in the rat
1992 • 219 citations
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans
2000 • 217 citations
Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
1989 • 216 citations
N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens
1997 • 211 citations
Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects
1998 • 199 citations
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
1998 • 197 citations
Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine
1997 • 197 citations
The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity
1984 • 181 citations
d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway
1978 • 165 citations
Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion
1998 • 162 citations
Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neurons
1990 • 157 citations
A glutamatergic deficiency model of schizophrenia
1999 • 155 citations
Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5-HT2 Receptor and α1-Adrenoreceptor Antagonism
1995 • 154 citations
The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.
1998 • 151 citations
Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats
1996 • 143 citations
Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response
1987 • 133 citations
Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons
1992 • 130 citations
Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens
1998 • 129 citations
Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
1996 • 125 citations
Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
1995 • 123 citations
MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists
1993 • 122 citations
Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study
1994 • 120 citations
Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells
1998 • 116 citations
Evidence for N-methyl-d-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-d-aspartate receptors
1995 • 113 citations
Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization
1993 • 111 citations
The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain
1998 • 109 citations
Ketamine and the conscious mind
1972 • 107 citations
Electrophysiological effects of selective ?-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons
1989 • 106 citations
The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study
1993 • 106 citations
SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters
1994 • 104 citations
CNS stimulants as tools in the study of schizophrenia
1984 • 100 citations
m-Chlorophenylpiperazine Effects in Neuroleptic-Free Schizophrenic Patients
1993 • 99 citations
Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: Anin vivo neurochemical assessment in the rhesus monkey
1995 • 93 citations
MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study
1991 • 92 citations
MK-801 elevates the etracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors
1993 • 92 citations
Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.
1995 • 91 citations
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
1994 • 90 citations
The effect of phencyclidine on dopamine synthesis and metabolism in rat striatum
1980 • 85 citations
Rating scales in research: The case of negative symptoms
1987 • 85 citations
The binding of ketamine to plasma proteins: Emphasis on human plasma
1983 • 85 citations
Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus
1999 • 84 citations
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
1999 • 82 citations
Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)
1993 • 80 citations
Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966
1997 • 77 citations
Effect of MK-801 on endogenous dopamine release in vivo
1990 • 77 citations
Glutamate pharmacology and the treatment of schizophrenia: current status and future directions
1995 • 73 citations
Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat
1986 • 68 citations
Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis
1992 • 63 citations
Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
1994 • 58 citations
Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry
1993 • 48 citations
Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl) guanidine on non-dopaminergic midbrain neurons
1993 • 47 citations
Clinical processes and central dopaminergic activity in psychotic disorders.
1980 • 44 citations
Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats
1995 • 43 citations
Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing
1990 • 42 citations
Peracetic acid as a superior oxidant for preparation of [123I]IBZM: A potential dopamine D‐2 receptor imaging agent
1989 • 38 citations
Recent Advances in the Teaching of Physics
1904 • 36 citations
σ and PCP receptors in human frontal cortex membranes
1988 • 32 citations
Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum
1982 • 32 citations
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine
1998 • 31 citations
The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity
1990 • 15 citations
Interactions between Catecholamines and Serotonin: Relevance to the Pharmacology of Schizophrenia
1997 • 14 citations
Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex
1989 • 13 citations
Synthesis of [123I]IBZM: a reliable procedure for routine clinical studies
1999 • 10 citations
Glutamate pharmacology and the treatment of schizophrenia
1995 • 4 citations